---
title: "Bio-S and others establish a new life and health venture capital partnership with an investment amount of 500 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252975366.md"
description: "According to the Qichacha APP, recently, Linhai City ZheSheng Collaborative Life and Health Venture Capital Partnership was established with a capital contribution of 500 million yuan. The business scope includes: venture capital; equity investment; engaging in investment activities with its own funds. Qichacha's equity penetration shows that the enterprise is jointly funded by Hangzhou MiPeng Enterprise Management Partnership under Bio-S and others"
datetime: "2025-08-14T06:38:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252975366.md)
  - [en](https://longbridge.com/en/news/252975366.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252975366.md)
generator: "portal-rs"
---

# Bio-S and others establish a new life and health venture capital partnership with an investment amount of 500 million yuan

According to the Qichacha APP, recently, Linhai City ZheSheng Collaborative Life Health Venture Capital Partnership was established with a capital contribution of 500 million yuan. The business scope includes: venture capital; equity investment; engaging in investment activities with its own funds. Qichacha's equity penetration shows that this enterprise is jointly funded by Hangzhou MiPeng Enterprise Management Partnership under Bio-S and others

### Related Stocks

- [301096.CN](https://longbridge.com/en/quote/301096.CN.md)

## Related News & Research

- [Subscribe for Symbiotec Pharmalab Ltd IPO; Ajcon Global](https://longbridge.com/en/news/296742246.md)
- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)
- [Across the country, Kennedy touts MAHA, but not vaccines](https://longbridge.com/en/news/296685679.md)
- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)
- [SP Group corrects disclosure, names Schur Finance as buyer of 31,500 shares at DKK 485](https://longbridge.com/en/news/296803384.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**